34.37  -0.05 (-0.15%)		10-02 16:00
Open: 34.655 High: 34.655 Volume: 134,542		Pre. Close: 34.42 Low: 34.2 Market Cap: 81(M)

Short term
Mid term
Targets	6-month :	41.27	1-year :	42.37
Resists	First :	35.33	Second :	36.27
Pivot price	34.76
Supports	First :	33.81	Second :	28.13
MAs	MA(5) :	34.88	MA(20) :	34.77
	MA(100) :	32.5	MA(250) :	29.9
MACD	MACD :	0	Signal :	0.1
%K %D	K(14,3) :	46.9	D(3) :	63.3
RSI	RSI(14): 45.6
52-week	High :	36.59	Low :	24.69

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ IBBQ ] has closed above bottom band by 25.7%. Bollinger Bands are 41% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	34.71 - 34.95	34.95 - 35.14
Low:	33.56 - 33.89	33.89 - 34.15
Close:	33.91 - 34.36	34.36 - 34.7

The Invesco Nasdaq Biotechnology ETF (IBBQ) seeks to mirror the investment performance of the Nasdaq Biotechnology Index. To achieve this, the Fund generally dedicates at least 90% of its total capital to the securities that make up this benchmark index. The underlying Index itself is specifically designed to gauge the returns of biotechnology and pharmaceutical companies whose shares are publicly traded on the Nasdaq Stock Market. Both the ETF and its corresponding Index undergo a yearly review and update of their composition each December, and their weightings are adjusted quarterly in March, June, September, and December.

Fri, 02 Oct 2026
(IBBQ) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Tue, 22 Sep 2026
Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH - The Motley Fool

Mon, 21 Sep 2026
Invesco Nasdaq Biotechnology ETF declares quarterly distribution of $0.2304 - TradingView

Thu, 10 Sep 2026
7 Best Biotech ETFs to Buy Now | Investing - money.usnews.com

Wed, 02 Sep 2026
Healthcare ETF Comparison: Fidelity's FHLC vs. Invesco's Biotech-Focused IBBQ - Yahoo Finance

Mon, 31 Aug 2026
How Invesco Nasdaq Biotechnology Etf (IBBQ) Affects Rotational Strategy Timing - Stock Traders Daily

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Financial Services
Industry: Asset Management - Global
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.